Weill Cornell Medical Center / The Rogosin Institute — New York, New York

Weill Cornell Medical Center / The Rogosin Institute is a clinical research site located in New York, New York, United States 10021.

Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.

Weill Cornell Medical Center / The Rogosin Institute has participated in 2 clinical trials.

Therapeutic areas: Colorectal Cancers, Pancreatic Adenocarcinoma Non-resectable, Pancreatic Adenocarcinoma Metastatic.

Sponsors: The Rogosin Institute.

Sponsor Feasibility Report

Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Weill Cornell Medical Center / The Rogosin Institute?

Weill Cornell Medical Center / The Rogosin Institute has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Weill Cornell Medical Center / The Rogosin Institute conducted?

Weill Cornell Medical Center / The Rogosin Institute has 2 clinical trials on record. Their work covers Colorectal Cancers, Pancreatic Adenocarcinoma Non-resectable, Pancreatic Adenocarcinoma Metastatic.

Is Weill Cornell Medical Center / The Rogosin Institute accredited by Crixeo Health?

Weill Cornell Medical Center / The Rogosin Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Weill Cornell Medical Center / The Rogosin Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.